ScholarIQanswers from OpenAlex

Prevalence of drug–drug interaction in atrial fibrillation patients based on a large claims data

PaperCitations, authors & open-access status

Prevalence of drug–drug interaction in atrial fibrillation patients based on a large claims data is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Prevalence of drug–drug interaction in atrial fibrillation patients based on a large claims data have?

ScholarIQcitation count

Prevalence of drug–drug interaction in atrial fibrillation patients based on a large claims data has 19 citations in the OpenAlex counts ScholarIQ stores.

When was Prevalence of drug–drug interaction in atrial fibrillation patients based on a large claims data published?

ScholarIQyear

Prevalence of drug–drug interaction in atrial fibrillation patients based on a large claims data has 2019 year in the ScholarIQ index.

What is the open-access status of Prevalence of drug–drug interaction in atrial fibrillation patients based on a large claims data?

ScholarIQoa status

Prevalence of drug–drug interaction in atrial fibrillation patients based on a large claims data has gold oa status in the ScholarIQ index.

What is the DOI of Prevalence of drug–drug interaction in atrial fibrillation patients based on a large claims data?

ScholarIQdoi

The DOI for Prevalence of drug–drug interaction in atrial fibrillation patients based on a large claims data is on the source record.

What is the PMID of Prevalence of drug–drug interaction in atrial fibrillation patients based on a large claims data?

ScholarIQpmid

The PMID for Prevalence of drug–drug interaction in atrial fibrillation patients based on a large claims data is on the source record.

What is the OpenAlex record for Prevalence of drug–drug interaction in atrial fibrillation patients based on a large claims data?

ScholarIQopenalex

The OpenAlex for Prevalence of drug–drug interaction in atrial fibrillation patients based on a large claims data is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial